Tandem Diabetes Care (TNDM) Assets Average (2014 - 2026)

Tandem Diabetes Care has reported Assets Average for 13 years, with the latest figure at $1.0 billion in Q1 2026.

• For the quarter ending Q1 2026, Assets Average rose 7.66% year-over-year to $1.0 billion; the trailing twelve-month figure through Mar 2026 stood at $1.0 billion (up 7.66% YoY), and the FY2025 full-year result was $924.4 million, down 3.73% from the prior year.
• Assets Average for Q1 2026 stood at $1.0 billion, up from $877.9 million in the prior quarter.
• The five-year high for Assets Average was $1.1 billion in Q4 2022, with the low at $875.2 million in Q3 2025.
• Historically, Assets Average has averaged $960.7 million across 5 years, with a median of $947.6 million in 2024.
• Annual changes were most pronounced in 2022 — Assets Average jumped 32.42% — and 2023, when it decreased 9.89%.
• Tandem Diabetes Care's Assets Average stood at $1.1 billion in 2022, then dropped by 9.89% to $946.3 million in 2023, then climbed by 1.73% to $962.7 million in 2024, then fell by 8.81% to $877.9 million in 2025, then advanced by 15.88% to $1.0 billion in 2026.
• The last three Assets Average figures came in at $1.0 billion (Q1 2026), $877.9 million (Q4 2025), and $875.2 million (Q3 2025), per Business Quant data.